GC
HZNP

Globeflex Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Globeflex Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,762
Closed -$348K – 507
2020
Q4 		$348K Sell
4,762
-11,040
-70% -$821K 0.07% 327
2020
Q3 		$1.23M Sell
15,802
-5,109
-24% -$352K 0.33% 88
2020
Q2 		$1.16M Sell
20,911
-55,108
-72% -$2.36M 0.29% 104
2020
Q1 		$2.25M Sell
76,019
-34,757
-31% -$1.18M 0.69% 14
2019
Q4 		$4.01M Sell
110,776
-9,921
-8% -$304K 0.75% 15
2019
Q3 		$3.29M Sell
120,697
-5,735
-5% -$148K 0.72% 20
2019
Q2 		$3.04M Sell
126,432
-124
-0.1% -$3.15K 0.63% 26
2019
Q1 		$3.35M Sell
126,556
-1,837
-1% -$43.5K 0.71% 18
2018
Q4 		$2.51M Buy
128,393
+3,734
+3% +$73.2K 0.6% 26
2018
Q3 		$2.44M Buy
124,659
+3,000
+2% +$57K 0.48% 36
2018
Q2 		$2.02M Sell
121,659
-6,000
-5% -$91.5K 0.41% 62
2018
Q1 		$1.81M Buy
127,659
+33,800
+36% +$499K 0.38% 68
2017
Q4 		$1.37M Buy
93,859
+31,466
+50% +$442K 0.38% 67
2017
Q3 		$791K Buy
62,393
+11,251
+22% +$143K 0.23% 168
2017
Q2 		$607K Hold
51,142
– – 0.15% 219
2017
Q1 		$756K Hold
51,142
– – 0.18% 211
2016
Q4 		$827K Hold
51,142
– – 0.21% 190
2016
Q3 		$927K Buy
+51,142
New +$999K 0.23% 162
2015
Q3 		– Sell
-22,800
Closed -$792K – 603
2015
Q2 		$792K Sell
22,800
-50,435
-69% -$1.54M 0.15% 265
2015
Q1 		$1.9M Sell
73,235
-415
-0.6% -$7.61K 0.36% 73
2014
Q4 		$949K Buy
73,650
+73,539
+66,251% +$921K 0.18% 227
2014
Q3 		$1K Sell
111
-46
-29% -$535 ﹤0.01% 516
2014
Q2 		$2K Sell
157
-31
-16% -$442 ﹤0.01% 472
2014
Q1 		$2K Buy
+188
New +$2.12K ﹤0.01% 470

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Globeflex Capital's HZNP Position: Q1 2021 in Review

Globeflex Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 4,762 shares — an estimated $348K sold.

Globeflex Capital first reported a position in HZNP in Q1 2014 and held it in 24 quarters. The position peaked at $4.01M in Q4 2019. 517 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

  • Globeflex Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Globeflex Capital sold 4,762 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $348K.
  • Globeflex Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 24 quarters.
  • Globeflex Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.01M in Q4 2019.
  • 517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Globeflex Capital's 13F filing for Q1 2021, filed 14 May 2021.